Neusignal Therapeutics
Tokyo
About Neusignal Therapeutics
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: neusignal-tx.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/neusignal-therapeutics-48510 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.